Clinical Trials in Salt Lake City

Showing 4681-4700 of 12,670 trials

Smart Autofocusing Eyeglasses

NCT03911596

A high-performance smart eyeglasses system with integrated sensing, actuation, control and data collection is being developed at the University of Utah. These smart eyeglasses use tunable lenses and integrated sensor technologies to correct blurred vision caused due to a major age-related condition called presbyopia.The objective of this study is to test this smart system on patients suffering from presbyopia aged 45 and above. The researchers intend to study the effect of these smart eyeglasses by qualitatively investigating the patient's visual acuity with this smart system. The results of this study and subsequent research have the potential to lead to major lifestyle improvements and better treatment for millions of presbyopic patients that are constrained by the limitation of current corrective eyeglass technologies. There are two main sources of fairly well understood problems that lead to presbyopia and loss of the eye focusing function. The adaptive eyeglasses used in these tests do not fix any of the internal eye problems. They just compensate externally for the loss of the eye focusing function caused by presbyopia. As such, the investigators intend to evaluate our system's effectiveness in terms of the sharpness of the perceived images.

Presbyopia

University of Utah17 participantsStarted Mar 2019

Salt Lake City, Utah, United States

COMPLETEDPhase 4< 1 mile

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

NCT00942968

The purpose of this study is to determine the long term tolerability and safety of dalteparin in subjects with cancer.

Cancer

Pfizer338 participantsStarted Jun 2009

Tucson, Arizona, United States • Pleasant Hill, California, United States • Torrance, California, United States +39 more locations

Smart Autofocusing Eyeglasses

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Find Trials by Condition in Salt Lake City

A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis

Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age

Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors

A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor

Study Using Negative Pressure to Reduce Apnea

Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)

Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Study of Turning Point Therapeutics LM-302 in Patients With Advance Solid Tumors

A Study to Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)

Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies

Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)

Letrozole for Lymphangioleiomyomatosis

Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients

Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma